COVID-19COVID-19 Drug TreatmentDexamethasone
Dr. Michael J. Kraut, MD
NPI1114926805
- Medicare services, 2020
- 38
- Part D claims, 2022
- 27
- Publications
- 16
- Clinical trials
- 10
- Industry payments
- $230,519
- Practice address
- 22101 Moross Rd, Detroit, MI 48236
- Practice phone
- Call (248) 552-0620
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Kraut's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael J. Kraut is a medical oncologist in Detroit, Michigan
Dr. Kraut practices in Detroit, Michigan.
Dr. Kraut's NPI, 1114926805, was assigned on July 15, 2005. Dr. Kraut graduated from Wayne State University School of Medicine in 1978. Dr. Kraut holds Michigan license 4301041322.
NPI and contact details
- NPI
- 1114926805NPI Registry (opens in a new tab)
- NPI enumeration date
- July 15, 2005
- NPI status
- Active
- Practice phone
- (248) 552-0620
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Michael J. Kraut's practice address is in Detroit, Michigan
Dr. Kraut's practice address in the NPI Registry is 22101 Moross Rd, Detroit, MI 48236, in Wayne County. The practice phone is (248) 552-0620.
- NPI Registry address22101 Moross Rd, Detroit, MI 48236 · Wayne CountyPhone(248) 552-0620
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Michael J. Kraut's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kraut practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Kraut's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kraut practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael J. Kraut is one of 171 medical oncologists in Michigan
Medical oncology is Dr. Kraut's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kraut is licensed in Michigan.
Specialties and state licenses
- Medical oncology, MichiganPrimary
Medical oncologists near Dr. Kraut
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael J. Kraut billed Medicare for 38 services in 2020
CMS data shows 38 Medicare services from Dr. Kraut across 2 procedure codes in 2020. Medicare paid $2,399 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 202038
Paid by Medicare$2,399
Procedure codes2
Dr. Kraut's Medicare services by type, 2019 to 2020
- 2019
- 2020
- Office and hospital visits
- 2019: 1092020: 3865%
Dr. Kraut compared with the Michigan median for medical oncologists, 2020
- Dr. Kraut
- Michigan median
- Medicare services
- 38vs 36490% below
- Part D claims
- 27vs 33492% below
Medians across 165 medical oncologists in Michigan with Dmand AI profiles that report each measure.
Dr. Kraut's most billed Medicare procedure codes, 2020
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kraut?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kraut and other medical oncologists in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael J. Kraut's patients have a median age of 79
Across all payers, Dmand AI patient panel data puts Dr. Kraut's median patient age at 79, with 100% women.
Dr. Kraut's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 79
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Dr. Michael J. Kraut wrote 27 Medicare Part D claims in 2022
In 2022, Dr. Kraut wrote 27 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $243,979 in total drug cost. In 2020, CMS named 12 claims across 1 drug.
Part D claims, 202227
Drugs named by CMS2
Total drug cost$243,979
Dr. Kraut's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2022
- 2020
- 2022
- Claims for drugs CMS names
- 2020: 122022: 27125%
Drugs named by CMS: 2 in 2022, 1 in 2020.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Kraut by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael J. Kraut has 16 publications on record
Dmand AI links 16 papers to Dr. Kraut, published from 2010 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Gene Expression Profiling, Macrophages and Transcriptome. Dr. Kraut has published most often in Immunity. Dr. Kraut's most frequent co-authors are Eyad I. Abu-Isa, MD, Subramanyeswara Rao Arekapudi, MD, MPH and Milind Y. Desai, MD.
Papers16
Years published2010 to 2024
Dr. Kraut's papers by year, 2010 to 2024
Topics Dr. Kraut writes about most
- Gene Expression Profiling
- Macrophages
- Transcriptome
- COVID-19
- Macrophage Activation
- Monocytes
- Cells, Cultured
- Chromatin
Dr. Kraut's most frequent co-authors
- Eyad I. Abu-Isa, MD1 shared paper
- Subramanyeswara Rao Arekapudi, MD, MPH1 shared paper
- Milind Y. Desai, MD1 shared paper
Recent publications by Dr. Kraut
Costs and Cost AnalysisDrug Evaluation, PreclinicalGene Expression Profiling
Cell Rep Methods
ChromatinChromatin Immunoprecipitation SequencingFreezing
ChemotaxisMacrophagesMacrophages, Alveolar
CiliaCystsGene Expression
See who Dr. Kraut researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kraut works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael J. Kraut has worked on 10 clinical trials
Dmand AI links Dr. Kraut to 10 clinical trials, 4 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma of Lung. National Cancer Institute (NCI) sponsors the most, 7.
Clinical trials with Dr. Kraut by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 1Phase 2/3: 1 trial
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Kraut's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Adenocarcinoma of Lung
- Gliosarcoma
- Lung Neoplasms
Investigators on the most trials with Dr. Kraut
- Cheryl M. Czerlanis, MD6 shared trials
- Thomas A. Hensing, MD6 shared trials
- Paul J. Hesketh, MD6 shared trials
Recent clinical trials with Dr. Kraut
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicDocetaxelDostarlimabFeladilimab
Small Cell Lung CarcinomaCarcinoma, BronchogenicCarboplatinCisplatinEtoposide
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation (opens in a new tab)
Active, not recruitingPhase 2/3
GliosarcomaGlioblastomaTemozolomideVeliparib
Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungRucaparib
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 3
Lung NeoplasmsThoracic NeoplasmsPembrolizumabCarboplatinPemetrexed
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael J. Kraut received $230,519 in industry payments from 2016 to 2022
CMS Open Payments shows 899 general payments to Dr. Kraut from 48 drug and device companies from 2016 to 2022. Speaker and faculty fees make up the largest share, 80% of the total. Bristol-Myers Squibb Company paid the most, $101,023.
General payments to Dr. Kraut by program year, 2016 to 2022
General payments to Dr. Kraut by kind, 2016 to 2022
$230.5Kin total
- Speaker and faculty fees$183,75880%
- Travel and lodging$21,0089%
- Food and beverage$13,8686%
- Consulting fees$11,5445%
- Education$3430%
Companies that paid Dr. Kraut the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael J. Kraut graduated from Wayne State University School of Medicine
Dr. Kraut graduated from Wayne State University School of Medicine in 1978.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael J. Kraut's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael J. Kraut
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael J. Kraut's NPI number?
Dr. Michael J. Kraut's NPI number is 1114926805. It was assigned on July 15, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael J. Kraut?
Dr. Michael J. Kraut is a medical oncologist in Detroit, Michigan. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Michael J. Kraut practice?
Dr. Kraut practices at 22101 Moross Rd, Detroit, MI 48236.
What is Dr. Michael J. Kraut's office phone number?
The practice phone on file for Dr. Kraut is (248) 552-0620.
What is Dr. Michael J. Kraut's medical license number?
Dr. Kraut holds Michigan license 4301041322.
Does Dr. Michael J. Kraut accept Medicare?
Yes. CMS data shows Dr. Kraut billed Medicare for 38 services in 2020.
What services does Dr. Michael J. Kraut bill to Medicare?
In 2020, Dr. Kraut's most billed Medicare services were hospital inpatient care (99232) and office visit, established patient (99214).
Where did Dr. Michael J. Kraut go to medical school?
Dr. Kraut graduated from Wayne State University School of Medicine in 1978.
What drugs does Dr. Michael J. Kraut prescribe most?
In 2022 Medicare Part D data, Dr. Kraut's most prescribed drugs by claims were Acyclovir and Pomalyst.
Has Dr. Michael J. Kraut received payments from drug or device companies?
CMS Open Payments shows $230,519 in general payments to Dr. Kraut from 48 companies from 2016 to 2022. The largest total came from Bristol-Myers Squibb Company.
Show 3 more questionsShow fewer questions
How long has Dr. Michael J. Kraut been practicing?
Dr. Kraut graduated from medical school in 1978, 48 years ago.
Does Dr. Michael J. Kraut do research?
Dmand AI links 16 publications to Dr. Kraut, published from 2010 to 2024. Dr. Kraut has worked on 10 clinical trials.
Who does Dr. Michael J. Kraut publish with?
Dr. Kraut's most frequent co-authors are Eyad I. Abu-Isa, MD (1 shared paper), Subramanyeswara Rao Arekapudi, MD, MPH (1 shared paper) and Milind Y. Desai, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card